Global and United States Central Nervous System Disorders Therapeutics Market Report & Forecast 2023-2028

Report ID: 1844823 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Central Nervous System Disorders Therapeutics Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Central Nervous System Disorders Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Central Nervous System Disorders Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Central Nervous System Disorders Therapeutics Market Size for the Year 2017-2028
    1.3 Central Nervous System Disorders Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Central Nervous System Disorders Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Central Nervous System Disorders Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Central Nervous System Disorders Therapeutics Market Dynamics
        1.4.1 Central Nervous System Disorders Therapeutics Industry Trends
        1.4.2 Central Nervous System Disorders Therapeutics Market Drivers
        1.4.3 Central Nervous System Disorders Therapeutics Market Challenges
        1.4.4 Central Nervous System Disorders Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Central Nervous System Disorders Therapeutics by Type
    2.1 Central Nervous System Disorders Therapeutics Market Segment by Type
        2.1.1 Depression
        2.1.2 MS
        2.1.3 bipolar disorder
        2.1.4 schizophrenia
        2.1.5 epilepsy
        2.1.6 AD
        2.1.7 Parkinson' s
        2.1.8 others
    2.2 Global Central Nervous System Disorders Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Central Nervous System Disorders Therapeutics Market Size by Type (2017-2028)
    2.4 United States Central Nervous System Disorders Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Central Nervous System Disorders Therapeutics Market Size by Type (2017-2028)
3 Central Nervous System Disorders Therapeutics by Application
    3.1 Central Nervous System Disorders Therapeutics Market Segment by Application
        3.1.1 Clinicals
        3.1.2 Hospitials
    3.2 Global Central Nervous System Disorders Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Central Nervous System Disorders Therapeutics Market Size by Application (2017-2028)
    3.4 United States Central Nervous System Disorders Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Central Nervous System Disorders Therapeutics Market Size by Application (2017-2028)
4 Global Central Nervous System Disorders Therapeutics Competitor Landscape by Company
    4.1 Global Central Nervous System Disorders Therapeutics Market Size by Company
        4.1.1 Top Global Central Nervous System Disorders Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Central Nervous System Disorders Therapeutics Revenue by Player (2017-2022)
    4.2 Global Central Nervous System Disorders Therapeutics Concentration Ratio (CR)
        4.2.1 Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Central Nervous System Disorders Therapeutics in 2021
        4.2.3 Global Central Nervous System Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Central Nervous System Disorders Therapeutics Headquarters, Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Central Nervous System Disorders Therapeutics Headquarters and Area Served
        4.3.2 Global Central Nervous System Disorders Therapeutics Companies Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Central Nervous System Disorders Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Central Nervous System Disorders Therapeutics Market Size by Company
        4.5.1 Top Central Nervous System Disorders Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Central Nervous System Disorders Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Central Nervous System Disorders Therapeutics Market Size by Region
    5.1 Global Central Nervous System Disorders Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Central Nervous System Disorders Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Central Nervous System Disorders Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Central Nervous System Disorders Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Central Nervous System Disorders Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Central Nervous System Disorders Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Central Nervous System Disorders Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Central Nervous System Disorders Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Central Nervous System Disorders Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Central Nervous System Disorders Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Central Nervous System Disorders Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Central Nervous System Disorders Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Details
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Introduction
        7.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022)
        7.1.5 Eli Lilly Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Details
        7.2.2 GlaxoSmithKline Business Overview
        7.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Introduction
        7.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022)
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Janssen Pharmaceuticals
        7.3.1 Janssen Pharmaceuticals Company Details
        7.3.2 Janssen Pharmaceuticals Business Overview
        7.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Introduction
        7.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022)
        7.3.5 Janssen Pharmaceuticals Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Details
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Central Nervous System Disorders Therapeutics Introduction
        7.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022)
        7.4.5 Novartis Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Company Details
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Central Nervous System Disorders Therapeutics Introduction
        7.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022)
        7.5.5 Pfizer Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Central Nervous System Disorders Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Central Nervous System Disorders Therapeutics Market Trends
    Table 3. Central Nervous System Disorders Therapeutics Market Drivers
    Table 4. Central Nervous System Disorders Therapeutics Market Challenges
    Table 5. Central Nervous System Disorders Therapeutics Market Restraints
    Table 6. Global Central Nervous System Disorders Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Central Nervous System Disorders Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Central Nervous System Disorders Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Central Nervous System Disorders Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Central Nervous System Disorders Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Central Nervous System Disorders Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Central Nervous System Disorders Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Central Nervous System Disorders Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Central Nervous System Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2021)
    Table 15. Top Players of Central Nervous System Disorders Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Central Nervous System Disorders Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Central Nervous System Disorders Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Central Nervous System Disorders Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Central Nervous System Disorders Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Central Nervous System Disorders Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Central Nervous System Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Central Nervous System Disorders Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Central Nervous System Disorders Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Central Nervous System Disorders Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Central Nervous System Disorders Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Central Nervous System Disorders Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Central Nervous System Disorders Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eli Lilly Company Details
    Table 31. Eli Lilly Business Overview
    Table 32. Eli Lilly Central Nervous System Disorders Therapeutics Product
    Table 33. Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Eli Lilly Recent Development
    Table 35. GlaxoSmithKline Company Details
    Table 36. GlaxoSmithKline Business Overview
    Table 37. GlaxoSmithKline Central Nervous System Disorders Therapeutics Product
    Table 38. GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. GlaxoSmithKline Recent Development
    Table 40. Janssen Pharmaceuticals Company Details
    Table 41. Janssen Pharmaceuticals Business Overview
    Table 42. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Product
    Table 43. Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Janssen Pharmaceuticals Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Central Nervous System Disorders Therapeutics Product
    Table 48. Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer Central Nervous System Disorders Therapeutics Product
    Table 53. Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Central Nervous System Disorders Therapeutics Product Picture
    Figure 2. Global Central Nervous System Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Central Nervous System Disorders Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Central Nervous System Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Central Nervous System Disorders Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Central Nervous System Disorders Therapeutics Market Share in Global 2017-2028
    Figure 7. Central Nervous System Disorders Therapeutics Report Years Considered
    Figure 8. Product Picture of Depression
    Figure 9. Product Picture of MS
    Figure 10. Product Picture of bipolar disorder
    Figure 11. Product Picture of schizophrenia
    Figure 12. Product Picture of epilepsy
    Figure 13. Product Picture of AD
    Figure 14. Product Picture of Parkinson' s
    Figure 15. Product Picture of others
    Figure 16. Global Central Nervous System Disorders Therapeutics Market Share by Type in 2022 & 2028
    Figure 17. Global Central Nervous System Disorders Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. Global Central Nervous System Disorders Therapeutics Market Share by Type (2017-2028)
    Figure 19. United States Central Nervous System Disorders Therapeutics Market Share by Type in 2022 & 2028
    Figure 20. United States Central Nervous System Disorders Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 21. United States Central Nervous System Disorders Therapeutics Market Share by Type (2017-2028)
    Figure 22. Product Picture of Clinicals
    Figure 23. Product Picture of Hospitials
    Figure 24. Global Central Nervous System Disorders Therapeutics Market Share by Application in 2022 & 2028
    Figure 25. Global Central Nervous System Disorders Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Central Nervous System Disorders Therapeutics Market Share by Application (2017-2028)
    Figure 27. United States Central Nervous System Disorders Therapeutics Market Share by Application in 2022 & 2028
    Figure 28. United States Central Nervous System Disorders Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Central Nervous System Disorders Therapeutics Market Share by Application (2017-2028)
    Figure 30. North America Central Nervous System Disorders Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. United States Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Mexico Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Central Nervous System Disorders Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. UK Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Vietnam Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America Central Nervous System Disorders Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. UAE Central Nervous System Disorders Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2017-2022)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2017-2022)
    Figure 61. Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Frequently Asked Questions
Central Nervous System Disorders Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Central Nervous System Disorders Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Central Nervous System Disorders Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cephalosporin Drugs

Cephalosporin Drugs market is segmented by region (country), players, by Type and by Application. ... Read More

Ceramic Balls

Ceramic Balls market is segmented by region (country), players, by Type and by Application. Playe ... Read More